[go: up one dir, main page]

PH30233A - Immunoactive peptides and antibodies and their use in anti-allergy treatment - Google Patents

Immunoactive peptides and antibodies and their use in anti-allergy treatment

Info

Publication number
PH30233A
PH30233A PH40691A PH40691A PH30233A PH 30233 A PH30233 A PH 30233A PH 40691 A PH40691 A PH 40691A PH 40691 A PH40691 A PH 40691A PH 30233 A PH30233 A PH 30233A
Authority
PH
Philippines
Prior art keywords
histamine
antibodies
peptide
phe
allergy treatment
Prior art date
Application number
PH40691A
Other languages
English (en)
Inventor
Dennis Raymond Stanworth
Ian Victor Lewin
Sarita Nayyar
Valerie Jones
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Publication of PH30233A publication Critical patent/PH30233A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH40691A 1989-06-15 1990-06-18 Immunoactive peptides and antibodies and their use in anti-allergy treatment PH30233A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898913737A GB8913737D0 (en) 1989-06-15 1989-06-15 A novel anti-allergy treatment

Publications (1)

Publication Number Publication Date
PH30233A true PH30233A (en) 1997-02-05

Family

ID=10658467

Family Applications (1)

Application Number Title Priority Date Filing Date
PH40691A PH30233A (en) 1989-06-15 1990-06-18 Immunoactive peptides and antibodies and their use in anti-allergy treatment

Country Status (18)

Country Link
US (1) US5601821A (pt)
EP (2) EP0477231B1 (pt)
JP (2) JPH04505922A (pt)
KR (1) KR0181313B1 (pt)
AT (1) ATE122401T1 (pt)
CA (1) CA2057860C (pt)
DE (1) DE69019348T2 (pt)
DK (1) DK0477231T3 (pt)
ES (1) ES2073028T3 (pt)
FI (1) FI104723B (pt)
GB (2) GB8913737D0 (pt)
IE (1) IE71677B1 (pt)
NO (1) NO914937L (pt)
NZ (1) NZ234085A (pt)
PH (1) PH30233A (pt)
PT (1) PT94381B (pt)
WO (1) WO1990015878A1 (pt)
ZA (1) ZA904670B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955076A (en) * 1989-06-15 1999-09-21 Peptide Therapeutics Limited Immunoactive peptides and antibodies and their use in anti-allergy treatment
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
US5958708A (en) * 1992-09-25 1999-09-28 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
US6066718A (en) * 1992-09-25 2000-05-23 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするｄｎａ
AU5957794A (en) * 1992-12-21 1994-07-19 Uab Research Foundation, The Compositions and method for the inhibition of phagocytes
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
AU687805B2 (en) * 1993-04-27 1998-03-05 United Biomedical Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
AU2195395A (en) * 1994-03-28 1995-10-17 United Biomedical Inc. Synthetic peptide based immunogens for the treatment of allergy
GB9412714D0 (en) * 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
GB9416321D0 (en) * 1994-08-12 1994-10-05 Peptide Therapeutics Ltd Peptides and antibodies and their use in treatment of carcinomas
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds
GB9422294D0 (en) * 1994-11-04 1994-12-21 Peptide Therapeutics Ltd Peptides for anti-allergy treatment
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
EP0885244B2 (en) 1996-03-01 2008-04-16 Novartis AG Peptide immunogens for vaccination against and treatment of allergy
US20010007771A1 (en) * 1996-05-29 2001-07-12 Sean M. Sullivan Cationic polymers and lipids for the delivery of nucleic acids
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US6573372B2 (en) 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of
EP1195161A3 (en) 2000-08-30 2002-07-24 Pfizer Products Inc. Anti-IgE vaccines
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
JP2003047482A (ja) * 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
RU2191602C1 (ru) * 2001-06-01 2002-10-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения аллергических и псевдоаллергических реакций
ATE447967T1 (de) 2001-09-14 2009-11-15 Cytos Biotechnology Ag Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung
RU2450827C2 (ru) 2002-07-19 2012-05-20 Цитос Биотехнологи Аг Композиции вакцин, содержащие наборы антигенов в виде амилоида бета 1-6
JP4459810B2 (ja) 2002-08-14 2010-04-28 マクロジェニクス，インコーポレーテッド ＦｃγＲＩＩＢ特異的抗体とその利用法
WO2005102385A1 (en) 2004-04-26 2005-11-03 Innate Pharma Adjuvant composition and methods for its use
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
NZ573622A (en) 2006-06-12 2011-12-22 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
EP2505209A1 (en) 2006-06-26 2012-10-03 MacroGenics, Inc. Fcgamma-RIIB-specific antibodies and methods of the use thereof
WO2010097012A1 (en) * 2009-02-25 2010-09-02 Tsewen Chang ANTI-CεmX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES
WO2013158274A1 (en) 2012-04-20 2013-10-24 Academia Sinica ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS
LT3430390T (lt) * 2016-03-18 2022-11-25 Genclis Molekulinė alergijos kilmė
CN111741768B (zh) 2017-10-31 2024-12-27 合一生技股份有限公司 治疗IgE介导的过敏性疾病
JP7503857B2 (ja) * 2022-04-11 2024-06-21 緑茵生技股▲ふん▼有限公司 抗アレルギー性ペプチド及びその免疫調節と抗アレルギーに用いられる用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
EP0000252B1 (en) * 1977-06-29 1982-02-03 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
AU1484688A (en) * 1987-02-20 1988-09-14 Imclone Systems, Inc. Monoclonal antibodies in vaccine formulations
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤
CA2082529A1 (en) * 1990-05-25 1991-11-26 Denis R. Stanworth Immunodiagnostic assay for rheumatoid arthritis
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
NO914937D0 (no) 1991-12-13
US5601821A (en) 1997-02-11
GB8913737D0 (en) 1989-08-02
PT94381B (pt) 1996-11-29
AU646808B2 (en) 1994-03-10
JP2000152783A (ja) 2000-06-06
EP0477231A1 (en) 1992-04-01
NZ234085A (en) 1991-09-25
EP0403312A1 (en) 1990-12-19
AU5814890A (en) 1991-01-08
FI104723B (fi) 2000-03-31
WO1990015878A1 (en) 1990-12-27
ATE122401T1 (de) 1995-05-15
DK0477231T3 (da) 1995-07-10
DE69019348T2 (de) 1995-09-21
DE69019348D1 (de) 1995-06-14
KR920702723A (ko) 1992-10-06
JPH04505922A (ja) 1992-10-15
IE71677B1 (en) 1997-02-26
ES2073028T3 (es) 1995-08-01
ZA904670B (en) 1992-02-26
EP0477231B1 (en) 1995-05-10
NO914937L (no) 1991-12-19
IE902154L (en) 1990-12-15
FI915891A0 (fi) 1991-12-13
CA2057860C (en) 2000-05-09
GB9013478D0 (en) 1990-08-08
PT94381A (pt) 1991-02-08
CA2057860A1 (en) 1990-12-16
KR0181313B1 (ko) 1999-04-01
IE902154A1 (en) 1991-01-02

Similar Documents

Publication Publication Date Title
GB9013478D0 (en) Immunoactive peptides and antibodies and their use in anti-allergy treatment
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
DE69522216D1 (de) Zielzellen-bindende chimäre Peptide
IL89541A0 (en) Urethane-protected amino acid-n-carboxyanhydrides and their use in the synthesis of polypeptides
CA2231603A1 (en) Chicken interleukin-15 and uses thereof
IE900502L (en) Conjugates
ATE118784T1 (de) Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen.
HUT35288A (en) Homogeneous immune interferon fragment and process for the paration thereof
SE8008415L (sv) Cyklisk analog for fagocytosstimulerande naturpeptid, dvs treonyl-cyklo-(-n-lysyl-prolyl-arginyl-)
SG63621A1 (en) Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
DE69836744D1 (de) Gruppe a streptokokken-impfstoff
PH31198A (en) Protein recognized by antibodies raised against native P28 of schitosoma mansoni.
ES2051647A1 (es) Procedimiento para la preparacion de calcitonina de salmon.
NZ234049A (en) Peptide epitopes of, and antibodies to htlv-1
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
IL76271A0 (en) Cross-reactive and protective epitopes of circumsporozoite proteins
PL288140A1 (en) Polypeptide, vaccine, expression vector, method of immunizing human organisms, method of obtaining polypeptide and method of obtaining such vaccine and expression vector
EP0299050A4 (en) ISOLATION OF SINGLE-CHAIN PROTEINS WITH FSH-SUPPRESSING ACTIVITY FROM FOLLICULAR LIQUID.
MY131433A (en) Novel metazoan parasite antigens having pepstatin binding activity and their use in vaccines
EP0350218A3 (en) Monoclonal antibodies recognizing gamma atrial natriuretic polypeptide, hybridomas producing such antibodies, and their preparation and use
GR3019825T3 (en) Protecting plasmodium falciparum hybrid proteins, containing partial sequences of malaria antigens HRPII and SERP
GB2299994A (en) Equine arteritis virus peptides antibodies and their use in a diagnostic test
WO2001024765A3 (en) Antigenic modification of polypeptides
Xu et al. PA161 ISOLATION OF PORCINE PANCREATIC POLYPEPTIDE AND PORCINE SPASMOLYTIC PEPTIDE